期刊文献+

喉癌治疗失败的原因分析 被引量:1

Analysis of Therapeutic Failure Cause of Carcinoma in The Larynx
下载PDF
导出
摘要 1975年至1990年间收治喉癌291例,3年内复发151例,复发率为51.9%。其中死亡54例,死于其它疾病者3例,死亡率为18.57%。291例中,Ⅱ期31例,Ⅲ期102例,Ⅳ期124例.混合型未分期34例。单纯放疗142例,喉部分切除44例,全喉切除42例,部分喉切除加放疗37例,局部激光汽化肿块切除26例。本文将根据临床分期,分型,治疗方法分析其治疗失败的原因。 cases of carcinoma of the larynx had been treated in our hospital from July, 1975 to July,1990' The recurrence tate of 3 years were 51. 9% (151/291), and the death rate was 18. 57%(54/291). All cases were clinically staged' Among them, 31 cases were staged i, 102cases,,andl24cases ac mixture type 34, 142cases received radiotherapy alon. 44 cases were operated partlarynx resection, and 42 cases whole larynx resection. 37 cases were performed part larynx resection plus radiotherapy. 26 cases received local mass laser excise. Accprding to clinical stage andclassification, we discussed-the best method of all the treatments to carcinoma of the larynx andits recurrence and death causes.
作者 孙学华
出处 《肿瘤防治研究》 CAS CSCD 北大核心 1994年第5期317-318,共2页 Cancer Research on Prevention and Treatment
关键词 喉癌 治疗 失败原因 喉肿瘤 neoplasm larynx treatment failure cause
  • 相关文献

参考文献1

共引文献1

同被引文献10

  • 1甘晓凡,周玉霞,蔡丽萍,刘明霞.中青年喉癌的疗效分析[J].中华耳鼻咽喉科杂志,1996,31(4):201-202. 被引量:1
  • 2Hunt KK, Vorburger SA. Hurdles and hopes for cancer treatment. Science, 2002,19: 415-416.
  • 3Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature, 1991, 351: 453-456.
  • 4Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathologic staging in squamous cell carcinoma of the head and neck. N Engl J Med, 1995, 332: 429-435.
  • 5Roth JA, Swisher SG, Meyn RE. p53 tumor suppressor gene therapy for cancer. Oncology, 1999, 13: 148-154.
  • 6Frank DK. Gene Therapy for head and neck cancer. Surg Oncol Clin N Am, 2002, 110: 708-726.
  • 7Vorburger SA, Hunt KK. Adenoviral gene therapy. Oncologist, 2002, 7: 46-59.
  • 8Wilson JM. Adenovirus-mediated gene transfer to liver. Adv Drug Deliv Rev, 2001, 46: 205-209.
  • 9D′Orazi G, Marchetti A, Crescenzi M, et al. Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting. J Gene Med, 2000, 2: 11-21.
  • 10胡俊兰,宋军健,葛俊恒,周维安.声门型喉癌T_3病变喉部分切除术后疗效评价[J].中华耳鼻咽喉科杂志,2000,35(2):138-140. 被引量:18

引证文献1

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部